EMA Authorised: Orphacol (cholic acid) — Theravia

View source ↗

Summary

Orphacol (cholic acid) has been authorised in the EU for its indicated digestive/metabolic indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Diseases
• Inborn Errors of Metabolism

Drugs mentioned

• Orphacol (cholic acid)

Snippet

Status: Authorised. Therapeutic area: Digestive System Diseases;Metabolism, Inborn Errors. MAH: Theravia. Decision date: 08/06/2026